Drug profile · INN
levoleucovorin
KHAPZORY
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
levoleucovorin (KHAPZORY) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
INN levoleucovorin
Brand KHAPZORY
Route INTRAVENOUS
Formulation POWDER
Frequently asked questions
What is levoleucovorin?
levoleucovorin (KHAPZORY) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for levoleucovorin?
KHAPZORY is a marketed brand name for levoleucovorin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of levoleucovorin?
levoleucovorin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.